PATRICK SOON-SHIONG

Insider Reports History

Location
El Segundo, CA
Signature
/s/ Patrick Soon-Shiong, /s/ Charles Kenworthy, Manager of MP 13 Ventures, on behalf of itself and as General Partner of Cambridge Equities, and /s/ Charles Kenworthy, Manager of California Capital Equity and Manager of Nant Capital
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PATRICK SOON-SHIONG:

Company Role Class Num Shares Value Price $ Report Date Ownership
ImmunityBio, Inc. Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Common Stock 29,757,911 $258,893,825 $8.70 22 Feb 2026 Direct
ImmunityBio, Inc. Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Common Stock 32,606,985 $192,707,281 $5.91 22 Feb 2026 Indirect
ImmunityBio, Inc. Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Common Stock 7,976,159 $47,139,099 $5.91 22 Feb 2026 See footnte
NantHealth, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 15,921,888 $31,219,638 $1.96 28 Aug 2023 Indirect
ImmunityBio, Inc. Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner Restricted Stock Units 114,329 $782,010 $3.42 22 Feb 2026 Direct

Insider Reports Filed by PATRICK SOON-SHIONG

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IBRX ImmunityBio, Inc. 22 Feb 2026 3 -$506,079 4 Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 24 Feb 2026, 20:05
IBRX ImmunityBio, Inc. 10 Feb 2026 3 -$821,621 4 Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 12 Feb 2026, 21:29
IBRX ImmunityBio, Inc. 22 Feb 2025 3 -$143,883 4 Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 25 Feb 2025, 21:11
IBRX ImmunityBio, Inc. 10 Feb 2025 2 $0 4 Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 12 Feb 2025, 20:17
IBRX ImmunityBio, Inc. 10 Dec 2024 6 +$126,402,412 4 Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 12 Dec 2024, 21:20
IBRX ImmunityBio, Inc. 22 Feb 2024 2 $0 4 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 26 Feb 2024, 16:36
IBRX ImmunityBio, Inc. 29 Dec 2023 2 +$410,000,000 4 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 03 Jan 2024, 21:53
IBRX ImmunityBio, Inc. 11 Sep 2023 9 +$199,999,997 4 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 13 Sep 2023, 21:07
/report/000095017023045521-soon-shiong-patrick-2023-08-28 NantHealth, Inc. 28 Aug 2023 2 +$15,999,975 4 Chief Executive Officer, Director, 10%+ Owner 30 Aug 2023, 17:26
IBRX ImmunityBio, Inc. 12 May 2023 1 +$30,455,859 4 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 16 May 2023, 20:30
IBRX ImmunityBio, Inc. 12 Dec 2022 2 -$5.11 4 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 14 Dec 2022, 15:23
IBRX ImmunityBio, Inc. 31 Aug 2022 6 +$315,096,248 4 Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner 08 Nov 2022, 15:01
IBRX ImmunityBio, Inc. 23 Mar 2022 2 $0 4 Executive Chairman, Director, 10%+ Owner 25 Mar 2022, 21:05
/report/000089924321035741-soon-shiong-patrick-2021-09-09 NantHealth, Inc. 09 Sep 2021 1 $0 4 Chairman and CEO, Director, 10%+ Owner 13 Sep 2021, 20:19
IBRX ImmunityBio, Inc. 10 Jun 2021 1 $0 4 Executive Chairman, Director, 10%+ Owner 14 Jun 2021, 18:38